FDA Awards Contract to ACCF for CHD Registry (posted: 10/02/09)

The FDA recently awarded a contract to the American College of Cardiology Foundation for the development of a congenital heart disease registry. The contract, intended to increase the scientific knowledge base for congenital heart disease, will further assist in the development of NCDR's IMPACT Registry. The IMPACT Registry, which is currently piloting 15 sites, tracks the prevalence, demographics, management and outcomes of pediatric and adult patients with congenital heart disease who are undergoing diagnostic catheterizations and catheter-based interventions.

 IMPACT Registry™ Pilot Launched (posted: 09/16/09)

Data collection has begun and will continue throughout the pilot. The registry will collect information about patients who undergo diagnostic and interventional catheterizations. This information will be used to help create evidence-based guidelines and provide data on demographics, acute management and in-hospital outcomes for a comprehensive selection of congenital patients.

 IMPACT Registry™ Pilot Webinars now in progress  (posted: 08/21/09)

 IMPACT Registry™ to Fill Gaps in Pediatric CHD Evidence, WSJ Writes (posted: 08/21/09)

The NCDR's IMPACT Registry™ recently gained some important national recognition in an article published in The Wall Street Journal on Wednesday, August 12. The article, titled “Little Hearts, Big Problems,” highlighted the plight of congenital heart disease (CHD) physicians and patients who struggle with a lack of both evidence and technology. Acknowledging that "hardly any of the myriad drugs and devices developed for the multibillion-dollar market for cardiovascular disease are designed with kids in mind,” the article goes on to discuss the role the Registry will play in addressing this issue. Gerard Martin, M.D., F.A.C.C., was quoted in the article discussing the soon-to-launch IMPACT Registry: “We hope IMPACT will become the standard by which safety and quality are judged for hospitals’ that treat congenital defects, says Gerard R. Martin, co-director of the Children’s National Heart Institute in Washington, who heads the registry effort. Dr. Martin expects the registry will eventually enable doctors to see whether surgery or less-invasive catheter-based procedures achieve better results for a variety of heart defects,” the article says.

Filling in some of the gaps in research will be NCDR’s IMPACT Registry™ (For Improving Pediatric and Adult Congenital Treatment). The IMPACT Registry will assess the prevalence, demographics, management and outcomes of pediatric and adult patients with congenital heart disease who are undergoing diagnostic catheterizations and catheter-based interventions. The IMPACT Registry will provide significant contributions to the knowledge base and outcomes associated with congenital heart disease. For more information, visit: http://www.impact.ncdr.com.